Dr. Anthony Farina, Librede’s Chief Scientific Officer, states: “We have been working on laying the foundation for a new chemical platform that will gain access to high value natural products. This new patent, which adds to our portfolio, demonstrates that THCA can be made using yeast, allowing for highly pure and consistent therapeutics to be produced at lower costs. We are working hard to improve the efficiency of our system to streamline the production of these compounds.”
Biosynthesis of high value complex natural products offers several advantages over agricultural production such as: consistency, supply chain stability, large reductions in costs, and reduced carbon footprint (less land, water, energy, no fertilizers, and no pesticides). The ability to obtain highly pure compounds in an environmentally and economically sustainable fashion is at the core of Librede’s mission.
Dr. Jason Poulos, CEO of Librede, explains: “Natural products have been and will continue to be a source of valuable therapeutics. Nature is the source, but it is not a sustainable factory. Large scale agricultural production of low abundant chemicals can have negative effects on the environment. Instead of using natural resources to grow massive fields of cannabis to make cannabinoids, fermentation offers us a sustainable solution. The future of cannabinoid production is coming into focus, and it’s looking more and more like a brewery.”
Librede is a synthetic biology company that uses biologically-based approaches to produce natural products with a focus on cannabinoids.